GCCRI Seminar Series: “Metabolic Phenotypes and Liabilities in Human Cancer“
Event Date & TimeOctober 4, 2019
LocationGreehey CCRI Auditorium, 2.160
Ralph DeBerardinis, M.D., Ph.D.
Chief, Division of Pediatric Genetics and Metabolism
"Metabolic Phenotypes and Liabilities in Human Cancer “
Save to CalendarAdd to calendar
About the Speaker(s)
Ralph DeBerardinis earned a B.S. in biology from St. Joseph’s University and M.D. and Ph.D. degrees from the University of Pennsylvania. Dr. DeBerardinis was the first trainee in the combined residency program in pediatrics and medical genetics at The Children’s Hospital of Philadelphia (CHOP) and received several awards for teaching and clinical care. He ultimately achieved board certification in pediatrics, medical genetics, and clinical biochemical genetics.
Dr. DeBerardinis performed postdoctoral research in Craig Thompson’s laboratory in the Penn Cancer Center from 2004 to 2007. He joined the faculty of the University of Texas Southwestern Medical Center in 2008 and joined the Children’s Medical Center Research Institute at UT Southwestern (CRI) shortly after its founding in 2012. Dr. DeBerardinis serves as chief of Pediatric Genetics and Metabolism at UT Southwestern and director of the Genetic and Metabolic Disease Program in the CRI. Dr. DeBerardinis became a Howard Hughes Medical Institute (HHMI) Investigator in 2018.
The DeBerardinis laboratory is interested in the role of altered metabolic states in human diseases, particularly pediatric inborn errors of metabolism and cancer. This research is tightly integrated with clinical activities in medical genetics, oncology, and radiology, providing seamless opportunities to examine the relevance of findings in patients.